These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 6430339)

  • 21. [Platelet aggregation induced by adenosine diphosphate, collagen and adrenaline in human platelet subpopulations].
    Nubile G; Di Gregorio M; Ridolfi D; D'Alonzo L; Izzi L
    Quad Sclavo Diagn; 1987 Sep; 23(3):331-40. PubMed ID: 3140287
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Inhibition of platelet thromboxane formation and phosphoinositides breakdown by osthole from Angelica pubescens.
    Ko FN; Wu TS; Liou MJ; Huang TF; Teng CM
    Thromb Haemost; 1989 Nov; 62(3):996-9. PubMed ID: 2556815
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Platelet function in platelet concentrates and in whole blood.
    Rodgers SE; Lloyd JV; Russell WJ
    Anaesth Intensive Care; 1985 Nov; 13(4):355-61. PubMed ID: 2934002
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Platelet aggregation in whole blood: the role of thromboxane A2 and adenosine diphosphate.
    Carter AJ; Heptinstall S
    Thromb Haemost; 1985 Oct; 54(3):612-6. PubMed ID: 3937261
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Increased platelet aggregation and intracellular calcium in hypertensive patients: effects of cyclo-oxygenase blockade.
    Lechi C; Arosio E; Minuz P; Guzzo P; Paluani F; Sinigaglia D; Lechi A
    J Hypertens Suppl; 1989 Dec; 7(6):S160-1. PubMed ID: 2517300
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Platelet thromboxane synthesis and release reactions in myeloproliferative disorders.
    Smith IL; Martin TJ
    Haemostasis; 1982; 11(2):119-27. PubMed ID: 6211399
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The effect of phospholipase inhibitor mepacrine on platelet aggregation, the platelet release reaction and fibrinogen binding to the platelet surface.
    Winocour PD; Kinlough-Rathbone RL; Mustard JF
    Thromb Haemost; 1981 Jun; 45(3):257-62. PubMed ID: 7281105
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Stored human platelets retain full aggregation potential in response to pairs of aggregating agents.
    DiMinno G; Silver MJ; Murphy S
    Blood; 1982 Mar; 59(3):563-8. PubMed ID: 6800418
    [No Abstract]   [Full Text] [Related]  

  • 29. Biphasic effect on platelet aggregation by phospholipase a purified from Vipera russellii snake venom.
    Teng CM; Chen YH; Ouyang C
    Biochim Biophys Acta; 1984 May; 772(3):393-402. PubMed ID: 6426517
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of methylprednisolone and hydrocortisone on aggregation of rabbit platelets induced by arachidonic acid and other aggregating substances.
    Glass F; Lippton H; Kadowitz PJ
    Thromb Haemost; 1981 Dec; 46(4):676-9. PubMed ID: 6800048
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Relationship between platelet aggregation, thromboxane synthesis and albumin concentration in nephrotic syndrome.
    Jackson CA; Greaves M; Patterson AD; Brown CB; Preston FE
    Br J Haematol; 1982 Sep; 52(1):69-77. PubMed ID: 6810912
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Inhibition of platelet aggregation by a new agent, Ticlopidine.
    Ashida SI; Abiko Y
    Thromb Haemost; 1979 Feb; 40(3):542-50. PubMed ID: 425067
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of phorbol 12-myristate 13-acetate (PMA) on agonist-induced arachidonate release and 5-hydroxytryptamine secretion in human platelets. Dependence of effects on agonist type and time of incubation with PMA.
    Krishnamurthi S; Joseph S; Kakkar VV
    Biochim Biophys Acta; 1987 Mar; 927(3):429-36. PubMed ID: 3101746
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Vernolepin: an antiplatelet compound of natural origin.
    Laekeman GM; De Clerck F; Vlietinck AJ; Herman AG
    Naunyn Schmiedebergs Arch Pharmacol; 1985 Oct; 331(1):108-13. PubMed ID: 3934564
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antiplatelet effect of butylidenephthalide.
    Teng CM; Chen WY; Ko WC; Ouyang CH
    Biochim Biophys Acta; 1987 Jun; 924(3):375-82. PubMed ID: 3109495
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Rat platelets aggregate in the absence of endogenous precursors of prostaglandin endoperoxides.
    Bult H; Bonta IL
    Nature; 1976 Dec; 264(5585):449-51. PubMed ID: 1004576
    [No Abstract]   [Full Text] [Related]  

  • 37. Platelet desensitization induced by arachidonic acid is not due to cyclo-oxygenase inactivation and involves the endoperoxide receptor.
    Carmo LG; Hatmi M; Rotilio D; Vargaftig BB
    Br J Pharmacol; 1985 Aug; 85(4):849-59. PubMed ID: 2994786
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Testosterone potentiation of ionophore and ADP induced platelet aggregation: relationship to arachidonic acid metabolism.
    Pilo R; Aharony D; Raz A
    Thromb Haemost; 1981 Aug; 46(2):538-42. PubMed ID: 6795741
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Effect of heparin on platelet aggregation in vitro].
    Róka L; Isert D
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1984; 111(6):735-49. PubMed ID: 6083949
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Neonatal platelet function: a membrane-related phenomenon?
    Corby DG; O'Barr TP
    Haemostasis; 1981; 10(4):177-85. PubMed ID: 7250785
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.